Sg Americas Securities, LLC Solid Biosciences Inc. Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$0.74 - $1.79 $12,483 - $30,197	-16,870 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$1.69 - $2.46 $31,802 - $46,292	-18,818 Reduced 52.73%	16,870 $30,000
Q3 2021 Nov 01, 2021	BUY	$2.38 - $3.77 $84,937 - $134,543	35,688 New	35,688 $85,000
Q1 2021 May 13, 2021	SELL	$5.37 - $10.72 $81,376 - $162,450	-15,154 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$3.08 - $7.79 $46,674 - $118,049	15,154 New	15,154 $115,000
Q3 2020 Nov 09, 2020	SELL	$2.02 - $3.08 $27,775 - $42,350	-13,750 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$2.1 - $3.42 $28,875 - $47,025	13,750 New	13,750 $40,000
Q4 2018 Feb 01, 2019	SELL	$21.32 - $46.34 $102,634 - $223,080	-4,814 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$36.35 - $51.7 $174,988 - $248,883	4,814 New	4,814 $227,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $30.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.